← Back to Clinical Trials
Recruiting NCT06136572
Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
Trial Parameters
Condition Tourette Syndrome
Sponsor University Hospital, Clermont-Ferrand
Study Type INTERVENTIONAL
Phase N/A
Enrollment 350
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-05-06
Completion 2026-05-05
Interventions
Rathus Assertiveness scale
Brief Summary
The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).
Eligibility Criteria
Inclusion Criteria: * Tourette syndrome * Participants aged 18 years or over Exclusion Criteria: * Participants under legal protection * Inability to complete questionnaires alone
Related Trials
NCT06136572
Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
View Trial →
NCT06889480
Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
View Trial →
NCT06679790
Trajectories of Change in Tourette Syndrome
View Trial →